CLINICAL_TRIALS trial_result · 2024-09-24

Clinical Trial Update: Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) [Phase 2]

Phase 2 trial assessing the efficacy and safety of AMG 570 in active systemic lupus erythematosus has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Amgen | Conditions: Systemic Lupus Erythematosus (SLE) | Phase 2 | Status: COMPLETED | Results posted: 2024-09-24